ยาแก้ซึมเศร้า
เชิงอรรถและอ้างอิง

↑  "antidepressant", ศัพท์บัญญัติอังกฤษ-ไทย, ไทย-อังกฤษ ฉบับราชบัณฑิตยสถาน (คอมพิวเตอร์) รุ่น ๑.๑ ฉบับ ๒๕๔๕, ๑. ยาแก้ซึมเศร้า ๒. -แก้ซึมเศร้า
1 2 3 4 5  Linde, K; Kriston, L; Rücker, G; Jamila, S; Schumann, I; Meissner, K; Sigterman, K; Schneider, A (Feb 2015). "Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis". Ann Fam Med. 13 (1): 69–79. doi:10.1370/afm.1687. PMC 4291268. PMID 25583895. In network meta-analysis, tricyclic and tetracyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), a serotonin-noradrenaline reuptake inhibitor (SNRI; venlafaxine), a low-dose serotonin antagonist and reuptake inhibitor (SARI; trazodone) and hypericum extracts were found to be significantly superior to placebo, with estimated odds ratios between 1.69 and 2.03. There were no statistically significant differences between these drug classes. Reversible inhibitors of monoaminoxidase A (rMAO-As) and hypericum extracts were associated with significantly fewer dropouts because of adverse effects compared with TCAs, SSRIs, the SNRI, a noradrenaline reuptake inhibitor (NRI), and noradrenergic and specific serotonergic antidepressant agents (NaSSAs). ... TCAs and SSRIs have the most solid evidence base. Further agents (hypericum, rMAO-As, SNRI, NRI, NaSSAs, SARI) showed some positive results, but limitations of the currently available evidence makes a clear recommendation on their place in clinical practice difficult.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2 3 4 5 6 7 8 9 10 11 12 13 14  Linde, K; Berner, MM; Kriston, L (2008). "St John's wort for major depression". Cochrane Database Syst Rev (4): CD000448. doi:10.1002/14651858.CD000448.pub3. PMID 18843608.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Hamilton, M (1960). "A rating scale for depression". J. Neurol. Neurosurg. Psychiatr. 23: 56–62. doi:10.1136/jnnp.23.1.56. PMC 495331. PMID 14399272.
↑  แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป, "ALGORITHM 1 ASSESSMENT OF MAJOR DEPRESSIVE DISORDER", หน้า 15
↑  "Depression in adults: The treatment and management of depression in adults". NICE guidelines [CG90]. National Institute for Health and Care Excellence (UK). Oct 2009. สืบค้นเมื่อ 2015-09-23.
↑  "PsychiatryOnline | APA Practice Guidelines | Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2014-02-19. สืบค้นเมื่อ 2016-10-03.
↑  แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป, "Summary of Recommendations", หน้า 13-14
↑  แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป Appendix 11, หน้า 62-63
↑  Kirsch, I; Moore, TJ; Scoboria, A; Nicholls, SS (2002). "The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration". Prevention & Treatment. 5. doi:10.1037/1522-3736.5.1.523a.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "Study: Antidepressant barely better than placebo". USA Today. 2002-07-07. สืบค้นเมื่อ 2008-11-06.
↑  Kirsch, I; Deacon, BJ; Huedo-Medina, TB; Scoboria, A; Moore, TJ; Johnson, BT (2008). "Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration". PLoS Medicine. 5 (2): e45. doi:10.1371/journal.pmed.0050045. PMC 2253608. PMID 18303940.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Fournier, JC; DeRubeis, RJ; Hollon, SD และคณะ (Jan 2010). "Antidepressant drug effects and depression severity: a patient-level meta-analysis". JAMA. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Borges, S; Chen, YF; Laughren, TP; Temple, R; Patel, HD; David, PA; Mathis, M; Unger, E; Yang, P; Khin, NA (2014). "Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration". J Clin Psychiatry. 75 (3): 205–14. doi:10.4088/JCP.13r08722. PMID 24717376.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "Depression in Adults (update)" (PDF). National Collaborating Centre for Mental Health Commissioned by the National Institute for Health and Care Excellence. www.nice.org.uk. pp. 282–292. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-06-12. สืบค้นเมื่อ 2013-11-20.
↑  Leucht, C; Huhn, M; Leucht, S (2012).  Leucht, C (บ.ก.). "Amitriptyline versus placebo for major depressive disorder". Cochrane Database of Systematic Reviews. 12: CD009138. doi:10.1002/14651858.CD009138.pub2. PMID 23235671.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Zhou, X; Ravindran, AV; Qin, B; Del Giovane, C; Li, Q; Bauer, M; Liu, Y; Fang, Y; da Silva, T; Zhang, Y; Fang, L; Wang, X; Xie, P (Apr 2015). "Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis". J Clin Psychiatry. 76 (4): e487-98. doi:10.4088/JCP.14r09204. PMID 25919841. Quetiapine and aripiprazole appear to be the most robust evidence-based options for augmentation therapy in patients with treatment-resistant depression{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Walsh, BT; Seidman, SN; Sysko, R; Gould, M (2002). "Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing". JAMA. 287 (14): 1840–7. doi:10.1001/jama.287.14.1840. PMID 11939870.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Freeman, MP; Mischoulon, D; Tedeschini, E; Goodness, T; Cohen, LS; Fava, M; Papakostas, GI (2010). "Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants". J Clin Psychiatry. 71 (6): 682–8. doi:10.4088/JCP.10r05976blu. PMID 20573327.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Lee, K; Bacchetti, P; Sim, I (2008).  Clarke, Mike (บ.ก.). "Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis". PLoS Medicine. 5 (9): e191. doi:10.1371/journal.pmed.0050191. PMC 2553819. PMID 18816163.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Whittington, CJ; Kendall, T; Fonagy, P; Cottrell, D; Cotgrove, A; Boddington, E (2004). "Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data". The Lancet. 363 (9418): 1341–5. doi:10.1016/S0140-6736(04)16043-1. PMID 15110490.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Ebrahim, Shanil (2015). "Meta-analyses with industry involvement are massively published and report no caveats for antidepressants". Journal of Clinical Epidemology. doi:10.1016/j.jclinepi.2015.08.021. PMID 26399904.
↑  Gibbons, RD; Hur, K; Brown, CH; Davis, JM; Mann, JJ (June 2012). "Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine". Archives of General Psychiatry. 69 (6): 572–9. doi:10.1001/archgenpsychiatry.2011.2044. PMC 3371295. PMID 22393205.
↑  Taylor, MJ; Freemantle, N; Geddes, JR; Bhagwagar, Z (2006). "Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis". Archives of General Psychiatry. 63 (11): 1217–23. doi:10.1001/archpsyc.63.11.1217. PMC 2211759. PMID 17088502.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study". National Institute of Mental Health. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-03-05. สืบค้นเมื่อ 2012-11-28.
↑  Fava, M; Rush, AJ; Wisniewski, SR; Nierenberg, AA; Alpert, JE; McGrath, PJ; Thase, ME; Warden, D; Biggs, M; Luther, JF; Niederehe, G; Ritz, L; Trivedi, MH (2006). "A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report". The American Journal of Psychiatry. 163 (7): 1161–72. doi:10.1176/appi.ajp.163.7.1161. PMID 16816220.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  Trivedi, MH; Fava, M; Wisniewski, SR; Thase, ME; Quitkin, F; Warden, D; Ritz, L; Nierenberg, AA; Lebowitz, BD; Biggs, MM; Luther, JF; Shores-Wilson, K; Rush, AJ (2006). "Medication Augmentation after the Failure of SSRIs for Depression". New England Journal of Medicine. 354 (12): 1243–52. doi:10.1056/NEJMoa052964. PMID 16554526.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Cusin, Cristina; Yang, Huaiyu; Yeung, Albert; Fava, Maurizio (2010). "Rating scales for depression" (PDF).  ใน Baer, L; Blais, MA (บ.ก.). Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. New York: Springer. pp. 7–36. ISBN 9781588299666. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2017-06-26. สืบค้นเมื่อ 2016-10-03.{{cite book}}:  CS1 maint: multiple names: authors list (ลิงก์)
↑  
Trivedi, MH; Rush, AJ; Wisniewski, SR; Nierenberg, AA; Warden, D; Ritz, L; Norquist, G; Howland, RH; Lebowitz, B; McGrath, PJ; Shores-Wilson, K; Biggs, MM; Balasubramani, GK; Fava, M (2006). "Evaluation of Outcomes with Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice". American Journal of Psychiatry. 163 (1): 28–40. doi:10.1176/appi.ajp.163.1.28. PMID 16390886.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Warden, D; Trivedi, MH; Wisniewski, SR; Davis, L; Nierenberg, AA; Gaynes, BN; Zisook, S; Hollon, SD; Balasubramani, GK; Howland, R; Fava, M; Stewart, JW; Rush, AJ (2007). "Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report". Am J Psychiatry. 164 (8): 1189–97. doi:10.1176/appi.ajp.2007.06071225. PMID 17671281.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑   Rush, AJ; Trivedi, MH; Wisniewski, SR; Stewart, JW; Nierenberg, AA; Thase, ME; Ritz, L; Biggs, MM; Warden, D; Luther, JF; Shores-Wilson, K; Niederehe, G; Fava, M (2006). "Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression". New England Journal of Medicine. 354 (12): 1231–42. doi:10.1056/NEJMoa052963. PMID 16554525.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Rush, AJ; Trivedi, MH; Wisniewski, SR และคณะ (Nov 2006). "Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report". Am J Psychiatry. 163 (11): 1905–17. doi:10.1176/appi.ajp.163.11.1905. PMID 17074942.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Warden, D; Rush, AJ; Trivedi, MH; Fava, M; Wisniewski, SR (2007). "The STAR*D Project results: A comprehensive review of findings". Current Psychiatry Reports. 9 (6): 449–59. doi:10.1007/s11920-007-0061-3. PMID 18221624.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Baghai, TC; Möller, HJ; Rupprecht, R (2006). "Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression". Current Pharmaceutical Design. 12 (4): 503–15. doi:10.2174/138161206775474422. PMID 16472142.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  
Ruhé, HG; Huyser, J; Swinkels, JA; Schene, AH (2006). "Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder". The Journal of Clinical Psychiatry. 67 (12): 1836–55. doi:10.4088/JCP.v67n1203. PMID 17194261.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Tranter, R; O'Donovan, C; Chandarana, P; Kennedy, S (2002). "Prevalence and outcome of partial remission in depression". Journal of Psychiatry & Neuroscience. 27 (4): 241–7. PMC 161658. PMID 12174733.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Byrne, SE; Rothschild, AJ (1998). "Loss of Antidepressant Efficacy During Maintenance Therapy". The Journal of Clinical Psychiatry. 59 (6): 279–88. doi:10.4088/JCP.v59n0602. PMID 9671339.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "Antidepressant Use in Persons Aged 12 and Over: United States, 2005-2008". www.cdc.gov. Products - Data Briefs - Number 76 - October 2011. Centers for Disease Control and Prevention. สืบค้นเมื่อ 2016-02-04.
↑  Mischoulon, D; Nierenberg, AA; Kizilbash, L; Rosenbaum, JF; Fava, M (2000). "Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians". Canadian Journal of Psychiatry. 45 (5): 476–81. PMID 10900529.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Bschor, T; Baethge, C (2010). "No evidence for switching the antidepressant: Systematic review and meta-analysis of RCTs of a common therapeutic strategy". Acta Psychiatrica Scandinavica. 121 (3): 174–9. doi:10.1111/j.1600-0447.2009.01458.x. PMID 19703121.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  DeBattista, C; Lembke, A (2005). "Update on augmentation of antidepressant response in resistant depression". Current Psychiatry Reports. 7 (6): 435–40. doi:10.1007/s11920-005-0064-x. PMID 16318821.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Lam, RW; Wan, DD; Cohen, NL; Kennedy, SH (2002). "Combining Antidepressants for Treatment-Resistant Depression". The Journal of Clinical Psychiatry. 63 (8): 685–93. doi:10.4088/JCP.v63n0805. PMID 12197448.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Goss, AJ; Kaser, M; Costafreda, SG; Sahakian, BJ; Fu, CH (2013). "Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials". The Journal of Clinical Psychiatry. 74 (11): 1101–7. doi:10.4088/JCP.13r08560. PMID 24330897.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Geddes, JR; Carney, SM; Davies, C; Furukawa, TA; Kupfer, DJ; Frank, E; Goodwin, GM (2003). "Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review". The Lancet. 361 (9358): 653–61. doi:10.1016/S0140-6736(03)12599-8. PMID 12606176.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Targum, SD (Mar 2014). "Identification and treatment of antidepressant tachyphylaxis". Innov Clin Neurosci. 11 (3–4): 24–8. PMC 4008298. PMID 24800130.
↑  
Fava, GA; Offidani, E (2011). "The mechanisms of tolerance in antidepressant action". Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35 (7): 1593–602. doi:10.1016/j.pnpbp.2010.07.026. PMID 20728491.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Fava, GA; Park, SK; Sonino, N (2006). "Treatment of recurrent depression". Expert Review of Neurotherapeutics. 6 (11): 1735–40. doi:10.1586/14737175.6.11.1735. PMID 17144786.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Petersen, TJ (2006). "Enhancing the efficacy of antidepressants with psychotherapy". Journal of Psychopharmacology. 20 (3 suppl): 19–28. doi:10.1177/1359786806064314. PMID 16644768.
1 2 3 4 5 6 7 8 9 10  
Brunton, Laurence L.; Chabner, Bruce; Knollmann, Björn C., บ.ก. (2011). Goodman and Gilman's The Pharmacological Basis of Therapeutics (12th ed.). New York: McGraw-Hill Professional. ISBN 978-0-07-162442-8.
1 2 3 4 5 6 7 8 9 10 11  "Side effects of antidepressant medications". UpToDate. Wolters Kluwer Health. เก็บจากแหล่งเดิมเมื่อ 2013-11-02. สืบค้นเมื่อ 2013-10-24.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  Royal Pharmaceutical Society of Great Britain. MARTINDALE - The Complete Drug Reference. Pharmaceutical Press. เก็บจากแหล่งเดิมเมื่อ 2013-07-26. สืบค้นเมื่อ 2013-10-31.
1 2 3 4 5 6 7 8 9 10 11 12  
Ernst E; Rand JI; Barnes J; Stevinson C (1998). "Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.)". European Journal of Clinical Pharmacology. 54 (8): 589–94. doi:10.1007/s002280050519. PMID 9860144. Collectively, the data suggest that hypericum is well tolerated, with an incidence of adverse reactions similar to that of placebo.
1 2 3  
Cipriani, A; Furukawa, TA; Salanti, G; Geddes, JR; Higgins, JP; Churchill, R; Watanabe, N; Nakagawa, A; Omori, IM; McGuire, H; Tansella, M; Barbui, C (2009). "Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis". Lancet. 373 (9665): 746–58. doi:10.1016/S0140-6736(09)60046-5. PMID 19185342.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2 3 4 5 6 7 8 9 10 11 12  
Taylor, D; Paton, C; Shitij, K (2012). The Maudsley prescribing guidelines in psychiatry. West Sussex: Wiley-Blackwell. ISBN 978-0-470-97948-8.
1 2  
White, N; Litovitz, T; Clancy, C (2008). "Suicidal antidepressant overdoses: a comparative analysis by antidepressant type". J Med Toxicol. 4 (4): 238–50. doi:10.1007/BF03161207. PMC 3550116. PMID 19031375.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2 3 4 5 6 7 8  
Rossi, S, บ.ก. (2013). Australian Medicines Handbook (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. ISBN 978-0-9805790-9-3.
↑  
Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW; van Hulst, AM; van der Mast, RC; van de Wetering, BJ (1996). "A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients". Psychopharmacology. 127 (3): 231–7. doi:10.1007/BF02246131. PMID 8912401.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW (1999). "Depressed in-patients respond differently to imipramine and mirtazapine". Pharmacopsychiatry. 32 (3): 87–92. doi:10.1055/s-2007-979200. PMID 10463374.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  van Moffaert, M; de Wilde, J; Vereecken, A; Dierick, M; Evrard, JL; Wilmotte, J; Mendlewicz, J (Mar 1995). "Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression". Int Clin Psychopharmacol. 10 (1): 3–9. doi:10.1097/00004850-199503000-00001. PMID 7622801.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Goodwin, GM (2009). "Clinical studies on the efficacy of agomelatine on depressive symptoms". CNS Drugs. 23 Suppl 2: 35–9. doi:10.2165/11318650-000000000-00000. PMID 19708724.
1 2 3 4 5 6 7 8 9 10 11  Voican, CS; Corruble, E; Naveau, S; Perlemuter, G (Apr 2014). "Antidepressant-induced liver injury: a review for clinicians". The American Journal of Psychiatry. 171 (4): 404–15. doi:10.1176/appi.ajp.2013.13050709. PMID 24362450.
↑  "AMOXAPINE tablet [Watson Laboratories, Inc.]". DailyMed. Watson Laboratories, Inc. Aug 2010. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-11-02. สืบค้นเมื่อ 2013-10-30.
1 2  Walker, R; Whittlesea, C, บ.ก. (2007) [1994]. Clinical Pharmacy and Therapeutics (4th ed.). Edinburgh: Churchill Livingstone Elsevier. ISBN 978-0-7020-4293-5.
1 2  Fishback, JA; Robson, MJ; Xu, YT; Matsumoto, RR (2010). "Sigma receptors: potential targets for a new class of antidepressant drug". Pharmacol. Ther. 127 (3): 271–82. doi:10.1016/j.pharmthera.2010.04.003. PMC 3993947. PMID 20438757.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  Kishimoto, A; Todani, A; Miura, J; Kitagaki, T; Hashimoto, K (2010). "The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report". Ann Gen Psychiatry. 9: 23. doi:10.1186/1744-859X-9-23. PMC 2881105. PMID 20492642.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Borkowska, A; Pilaczyńska, E; Araszkiewicz, A; Rybakowski, J (2002). "[The effect of sertraline on cognitive functions in patients with obsessive-compulsive disorder]". Psychiatr. Pol. (ภาษาโปแลนด์). 36 (6 Suppl): 289–95. PMID 12647451.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Schmitt, JA; Ramaekers, JG; Kruizinga, MJ; van Boxtel, MP; Vuurman, EF; Riedel, WJ (2002). "Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man". J. Psychopharmacol. 16 (3): 207–14. doi:10.1177/026988110201600303. PMID 12236626.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Joint Formulary Committee (2013). British National Formulary (BNF) (65 ed.). London, UK: Pharmaceutical Press. ISBN 978-0-85711-084-8.
1 2  "Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults" (PDF). NICE. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2012-10-21. สืบค้นเมื่อ 2013-02-20.
1 2  Kapczinski, F; Lima, MS; Souza, JS; Schmitt, R (2003).  Kapczinski, Flavio FK (บ.ก.). "Antidepressants for generalized anxiety disorder". Cochrane Database Syst Rev (2): CD003592. doi:10.1002/14651858.CD003592. PMID 12804478.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "Obsessive-compulsive disorder: Core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder" (PDF). Nov 2005. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2008-12-06. สืบค้นเมื่อ 2016-10-03.
↑  
Arroll, B; Elley, CR; Fishman, T; Goodyear-Smith, FA; Kenealy, T; Blashki, G; Kerse, N; Macgillivray, S (2009).  Arroll, Bruce (บ.ก.). "Antidepressants versus placebo for depression in primary care". The Cochrane Database of Systematic Reviews (3): CD007954. doi:10.1002/14651858.CD007954. PMID 19588448.{{cite journal}}:  CS1 maint: multiple names: authors list (ลิงก์)
↑  "Medscape Log In". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-04-13. สืบค้นเมื่อ 2016-10-03.
↑  
Fineberg, NA; Brown, A; Reghunandanan, S; Pampaloni, I (2012). "Evidence-based pharmacotherapy of obsessive-compulsive disorder". The International Journal of Neuropsychopharmacology. 15 (8): 1173–91. doi:10.1017/S1461145711001829. PMID 22226028.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
"Sertraline prescribing information" (PDF). FDA. สืบค้นเมื่อ 2015-01-30.
↑  
"Paroxetine prescribing information" (PDF). Apotex. สืบค้นเมื่อ 2015-01-30.
1 2 3  "Eating disorders in over 8s: management" (PDF). NICE. Jan 2004.
↑  "Bupropion". MedlinePlus. 2016-02-15. สืบค้นเมื่อ 2016-03-10.
1 2  "National Guideline Clearinghouse | Practice guideline for the treatment of patients with eating disorders". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-05-25. สืบค้นเมื่อ 2016-10-03.
↑  Flament, MF; Bissada, H; Spettigue, W (Mar 2012). "Evidence-based pharmacotherapy of eating disorders". The International Journal of Neuropsychopharmacology. 15 (2): 189–207. doi:10.1017/S1461145711000381. PMID 21414249.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Häuser, W; Wolfe, F; Tölle, T; Uçeyler, N; Sommer, C (Apr 2012). "The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis". CNS Drugs. 26 (4): 297–307. doi:10.2165/11598970-000000000-00000. PMID 22452526.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  doi:10.1136/ard.2007.071522
This citation will be automatically completed in the next few minutes. You can jump the queue or  Full Article PDF (135 KB)
↑  Lunn, MP; Hughes, RA; Wiffen, PJ (2014). "Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia". Cochrane Database Syst Rev. 1: CD007115. doi:10.1002/14651858.CD007115.pub3. PMID 24385423.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  update Moore, RA; Derry, S; Aldington, D; Cole, P; Wiffen, PJ (2012). "Amitriptyline for neuropathic pain and fibromyalgia in adults". Cochrane Database Syst Rev. 12: CD008242. doi:10.1002/14651858.CD008242.pub2. PMID 23235657.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Birmes, P; Coppin, D; Schmitt, L; Lauque, D (2003). "Serotonin syndrome: a brief review". CMAJ. 168 (11): 1439–42. PMC 155963. PMID 12771076.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Boyer, EW; Shannon, M (2005). "The serotonin syndrome" (PDF). N. Engl. J. Med. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-06-18.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Mason, PJ; Morris, VA; Balcezak, TJ (2000). "Serotonin syndrome. Presentation of 2 cases and review of the literature". Medicine. 79 (4): 201–9. doi:10.1097/00005792-200007000-00001. PMID 10941349.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Sampson, E; Warner, JP (1999). "Serotonin syndrome: potentially fatal but difficult to recognize". Br J Gen Pract. 49 (448): 867–8. PMC 1313553. PMID 10818648.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Rao, Sathyanarayana TS; Yeragani, VK (2009). "Hypertensive crisis and cheese". Indian J Psychiatry. 51 (1): 65–6. doi:10.4103/0019-5545.44910. PMC 2738414. PMID 19742203.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)